DIANTHUS THERAPEUTICS INC (DNTH) Stock Analyst Ratings
NASDAQ:DNTH - Nasdaq - US2528281080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 88% to DNTH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.65. This target is 123.27% above the current price.
DNTH was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about DNTH.
In the previous month the buy percentage consensus was at a similar level.
DNTH was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | TD Cowen | Initiate | Buy |
| 2024-11-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-10-03 | Oppenheimer | Initiate | Outperform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-07-26 | Baird | Initiate | Outperform |
| 2024-06-27 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-16 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-04-18 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-03-22 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-02-15 | Stifel | Initiate | Buy |
| 2024-01-26 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-12-26 | Jefferies | Initiate | Buy |
| 2023-11-22 | Wedbush | Initiate | Outperform |
| 2023-09-28 | Raymond James | Initiate | Outperform |